FDA
-
-
-
-
-
-
-
bioAffinity (BIAF) Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
-
-
-
-
-
-
-
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
-
-
-
-
-
-
-
bioAffinity Technologies Reports First Quarter 2023 Financial Results
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

